Amgen puts its KRAS hopes on ‘Navy Seals’ team of drug hunters
Amgen's never moved faster. In late August of last year, the first patient enrolled in...
Amgen's never moved faster. In late August of last year, the first patient enrolled in...
This investor centre was built by Reach Markets
©2022 Reach Markets
To stay up to date with Prescient Therapeutics news and events, please register your details.